EN
enGene Holdings Inc. Warrants
ENGNW · NASDAQ
$0.20 -90.48% (-$1.90)
1M -20.06%
Market Cap $10.8M
P/E Ratio -
Div. Yield -
ROE 2.10%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.05x
PEG N/A
P/S N/A
Growth
78 /100
Growing Book val. growth 9.59%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 2.10%
ROA 1.70%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 9.79x
Int. coverage -44.28x
Debt/Equity 0.03x
Stability
19 /100
Unstable EPS volatility 128,900.54%
Profitable years 0
Beta -0.28x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ENGNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ronald H. W. Cooper
Employees
82
Headquarters
Montreal
Prihajajoči dogodki
23 DEC.
Earnings
Upcoming earnings report